• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.曼氏血吸虫硫氧还蛋白谷胱甘肽还原酶催化机制的研究。
Biochemistry. 2011 Jul 5;50(26):5870-82. doi: 10.1021/bi200107n. Epub 2011 Jun 10.
2
Kinetic characterization of wild-type and mutant human thioredoxin glutathione reductase defines its reaction and regulatory mechanisms.野生型和突变型人硫氧还蛋白谷胱甘肽还原酶的动力学特征定义了其反应和调节机制。
FEBS J. 2018 Feb;285(3):542-558. doi: 10.1111/febs.14357. Epub 2017 Dec 29.
3
Comparative modeling of thioredoxin glutathione reductase from Schistosoma mansoni: a multifunctional target for antischistosomal therapy.曼氏血吸虫硫氧还蛋白谷胱甘肽还原酶的比较建模:抗血吸虫治疗的多功能靶点
J Mol Graph Model. 2009 Feb;27(6):665-75. doi: 10.1016/j.jmgm.2008.10.009. Epub 2008 Nov 6.
4
Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.通过分子对接探索硫氧还蛋白谷胱甘肽还原酶潜在抑制剂的可能结合模式。
Mol Med Rep. 2015 Oct;12(4):5787-95. doi: 10.3892/mmr.2015.4119. Epub 2015 Jul 27.
5
Probing the site of glutathione reduction by thioredoxin/glutathione reductase from Schistosoma mansoni under anaerobic conditions.在无氧条件下探究曼氏血吸虫硫氧还蛋白/谷胱甘肽还原酶还原的位点。
Arch Biochem Biophys. 2024 Nov;761:110162. doi: 10.1016/j.abb.2024.110162. Epub 2024 Sep 23.
6
The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase.曼氏血吸虫的二硫键氧化还原系统以及多功能酶硫氧还蛋白谷胱甘肽还原酶的重要性。
Mol Biochem Parasitol. 2002 Apr 30;121(1):129-39. doi: 10.1016/s0166-6851(02)00031-2.
7
Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase.处于十字路口的谷胱甘肽还原酶和硫氧还蛋白还原酶:曼氏血吸虫硫氧还蛋白谷胱甘肽还原酶的结构
Proteins. 2008 Aug 15;72(3):936-45. doi: 10.1002/prot.21986.
8
The Enzymatic and Structural Basis for Inhibition of Echinococcus granulosus Thioredoxin Glutathione Reductase by Gold(I).金(I)抑制细粒棘球绦虫硫氧还蛋白谷胱甘肽还原酶的酶学和结构基础
Antioxid Redox Signal. 2017 Dec 20;27(18):1491-1504. doi: 10.1089/ars.2016.6816. Epub 2017 Jun 26.
9
Role of cysteine 337 and cysteine 340 in flavoprotein that functions as NADH oxidase from Amphibacillus xylanus studied by site-directed mutagenesis.通过定点诱变研究木聚糖两栖芽孢杆菌中作为NADH氧化酶发挥作用的黄素蛋白中半胱氨酸337和半胱氨酸340的作用。
J Biol Chem. 1995 Mar 17;270(11):5812-7. doi: 10.1074/jbc.270.11.5812.
10
Role of the glutaredoxin domain and FAD in the stabilization of thioredoxin glutathione reductase.谷氧还蛋白结构域和 FAD 在稳定硫氧还蛋白谷胱甘肽还原酶中的作用。
Arch Biochem Biophys. 2018 Oct 15;656:38-45. doi: 10.1016/j.abb.2018.09.002. Epub 2018 Sep 8.

引用本文的文献

1
Time-Dependent Kinetic Complexities in Enzyme Assays: A Review.酶活性测定中的时间依赖性动力学复杂性:综述
Biomolecules. 2025 Apr 30;15(5):641. doi: 10.3390/biom15050641.
2
The "Doorstop Pocket" In Thioredoxin Reductases─An Unexpected Druggable Regulator of the Catalytic Machinery.硫氧还蛋白还原酶中的“门挡口袋”——催化机制中意想不到的可药物调节因子。
J Med Chem. 2024 Sep 26;67(18):15947-15967. doi: 10.1021/acs.jmedchem.4c00669. Epub 2024 Sep 9.
3
Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions.通过基于配体的药物设计、分子对接、分子动力学模拟和药代动力学预测揭示血吸虫病的有效抑制剂。
PLoS One. 2024 Jun 26;19(6):e0302390. doi: 10.1371/journal.pone.0302390. eCollection 2024.
4
Fragment library screening by X-ray crystallography and binding site analysis on thioredoxin glutathione reductase of Schistosoma mansoni.应用 X 射线晶体学和对曼氏血吸虫硫氧还蛋白谷胱甘肽还原酶的结合部位分析进行片段文库筛选。
Sci Rep. 2024 Jan 18;14(1):1582. doi: 10.1038/s41598-024-52018-2.
5
Assigning function to active site residues of thioredoxin/glutathione reductase from analysis of transient state reductive half-reactions with variant forms of the enzyme.通过对该酶变体形式的瞬态还原半反应进行分析,确定硫氧还蛋白/谷胱甘肽还原酶活性位点残基的功能。
Front Mol Biosci. 2023 Sep 13;10:1258333. doi: 10.3389/fmolb.2023.1258333. eCollection 2023.
6
Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo.体内具有杀血吸虫活性的硫氧还蛋白-谷胱甘肽还原酶的非共价抑制剂。
Nat Commun. 2023 Jun 22;14(1):3737. doi: 10.1038/s41467-023-39444-y.
7
Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus.寄生丝状线虫马来布鲁线虫和盘尾丝虫硫氧还蛋白还原酶硒蛋白的生化与结构表征
Redox Biol. 2022 May;51:102278. doi: 10.1016/j.redox.2022.102278. Epub 2022 Mar 4.
8
Probing the Surface of a Parasite Drug Target Thioredoxin Glutathione Reductase Using Small Molecule Fragments.利用小分子片段探测寄生虫药物靶点硫氧还蛋白-谷胱甘肽还原酶的表面。
ACS Infect Dis. 2021 Jul 9;7(7):1932-1944. doi: 10.1021/acsinfecdis.0c00909. Epub 2021 May 5.
9
Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.重新利用金诺芬及评估一种新型一价金化合物用于寻找人类和牛寄生虫病的治疗方法:从原生动物感染到蠕虫感染
Molecules. 2020 Nov 1;25(21):5075. doi: 10.3390/molecules25215075.
10
Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.针对硒蛋白硫氧还蛋白还原酶的先导化合物的特征,用于治疗血吸虫病。
ACS Infect Dis. 2020 Mar 13;6(3):393-405. doi: 10.1021/acsinfecdis.9b00354. Epub 2020 Jan 24.

本文引用的文献

1
Linked thioredoxin-glutathione systems in platyhelminth parasites: alternative pathways for glutathione reduction and deglutathionylation.扁形动物门寄生虫中的硫氧还蛋白-谷胱甘肽系统:谷胱甘肽还原和去谷胱甘肽化的替代途径。
J Biol Chem. 2011 Feb 18;286(7):4959-67. doi: 10.1074/jbc.M110.170761. Epub 2010 Nov 4.
2
Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography.通过 X 射线晶体学绘制曼氏血吸虫硫氧还蛋白谷胱甘肽还原酶的催化循环图。
J Biol Chem. 2010 Oct 15;285(42):32557-67. doi: 10.1074/jbc.M110.141960. Epub 2010 Jul 21.
3
Differing views of the role of selenium in thioredoxin reductase.对硒在硫氧还蛋白还原酶中的作用的不同看法。
Amino Acids. 2011 Jun;41(1):73-89. doi: 10.1007/s00726-010-0494-6. Epub 2010 Feb 21.
4
CUG start codon generates thioredoxin/glutathione reductase isoforms in mouse testes.CUG 起始密码子在小鼠睾丸中产生硫氧还蛋白/谷胱甘肽还原酶同工酶。
J Biol Chem. 2010 Feb 12;285(7):4595-602. doi: 10.1074/jbc.M109.070532. Epub 2009 Dec 14.
5
Thiol-disulfide exchange between glutaredoxin and glutathione.谷胱甘肽还原酶和谷胱甘肽之间的巯基-二硫键交换。
Biochemistry. 2010 Feb 2;49(4):810-20. doi: 10.1021/bi9015956.
6
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.结构机制见解及一氧化氮供体的作用指导恶二唑-2-氧化物作为抗血吸虫病治疗药物的研发。
J Med Chem. 2009 Oct 22;52(20):6474-83. doi: 10.1021/jm901021k.
7
Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects.金诺芬对曼氏血吸虫硫氧还蛋白-谷胱甘肽还原酶的抑制作用:结构和动力学方面
J Biol Chem. 2009 Oct 16;284(42):28977-85. doi: 10.1074/jbc.M109.020701. Epub 2009 Aug 26.
8
No selenium required: reactions catalyzed by mammalian thioredoxin reductase that are independent of a selenocysteine residue.无需硒:哺乳动物硫氧还蛋白还原酶催化的与硒代半胱氨酸残基无关的反应。
Biochemistry. 2009 Jul 7;48(26):6213-23. doi: 10.1021/bi802146w.
9
Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.关注哺乳动物硫氧还蛋白还原酶——具有多种功能的重要硒蛋白。
Biochim Biophys Acta. 2009 Jun;1790(6):495-526. doi: 10.1016/j.bbagen.2009.01.014. Epub 2009 Feb 11.
10
Protein S-glutathionylation: a regulatory device from bacteria to humans.蛋白质S-谷胱甘肽化:从细菌到人类的一种调控机制
Trends Biochem Sci. 2009 Feb;34(2):85-96. doi: 10.1016/j.tibs.2008.11.002. Epub 2009 Jan 8.

曼氏血吸虫硫氧还蛋白谷胱甘肽还原酶催化机制的研究。

Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.

机构信息

Department of Microbiology and Immunology, Rush University Medical Center, Chicago, Illinois 60612, United States.

出版信息

Biochemistry. 2011 Jul 5;50(26):5870-82. doi: 10.1021/bi200107n. Epub 2011 Jun 10.

DOI:10.1021/bi200107n
PMID:21630672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3658134/
Abstract

Thioredoxin glutathione reductase from Schistosoma mansoni (SmTGR) catalyzes the reduction of both thioredoxin and glutathione disulfides (GSSG), thus playing a crucial role in maintaining redox homeostasis in the parasite. In line with this role, previous studies have demonstrated that SmTGR is a promising drug target for schistosomiasis. To aid in the development of efficacious drugs that target SmTGR, it is essential to understand the catalytic mechanism of SmTGR. SmTGR is a dimeric flavoprotein in the glutathione reductase family and has a head-to-tail arrangement of its monomers; each subunit has the components of both a thioredoxin reductase (TrxR) domain and a glutaredoxin (Grx) domain. However, the active site of the TrxR domain is composed of residues from both subunits: FAD and a redox-active Cys-154/Cys-159 pair from one subunit and a redox-active Cys-596'/Sec-597' pair from the other; the active site of the Grx domain contains a redox-active Cys-28/Cys-31 pair. Via its Cys-28/Cys-31 dithiol and/or its Cys-596'/Sec-597' thiol-selenolate, SmTGR can catalyze the reduction of a variety of substrates by NADPH. It is presumed that SmTGR catalyzes deglutathionylation reactions via the Cys-28/Cys-31 dithiol. Our anaerobic titration data suggest that reducing equivalents from NADPH can indeed reach the Cys-28/Cys-31 disulfide in the Grx domain to facilitate reductions effected by this cysteine pair. To clarify the specific chemical roles of each redox-active residue with respect to its various reactivities, we generated variants of SmTGR. Cys-28 variants had no Grx deglutathionylation activity, whereas Cys-31 variants retained partial Grx deglutathionylation activity, indicating that the Cys-28 thiolate is the nucleophile initiating deglutathionylation. Lags in the steady-state kinetics, found when wild-type SmTGR was incubated at high concentrations of GSSG, were not present in Grx variants, indicating that this cysteine pair is in some way responsible for the lags. A Sec-597 variant was still able to reduce a variety of substrates, albeit slowly, showing that selenocysteine is important but is not the sole determinant for the broad substrate tolerance of the enzyme. Our data show that Cys-520 and Cys-574 are not likely to be involved in the catalytic mechanism.

摘要

曼氏血吸虫硫氧还蛋白-谷胱甘肽还原酶(SmTGR)可催化硫氧还蛋白和谷胱甘肽二硫化物(GSSG)的还原,因此在寄生虫的氧化还原稳态维持中发挥关键作用。与这一作用一致,先前的研究表明 SmTGR 是血吸虫病的一个很有前途的药物靶点。为了开发针对 SmTGR 的有效药物,了解 SmTGR 的催化机制至关重要。SmTGR 是谷胱甘肽还原酶家族中的二聚体黄素蛋白,其单体呈头尾排列;每个亚基都具有硫氧还蛋白还原酶(TrxR)结构域和谷氧还蛋白(Grx)结构域的组成部分。然而,TrxR 结构域的活性位点由两个亚基的残基组成:一个亚基的 FAD 和一个氧化还原活性的 Cys-154/Cys-159 对,另一个亚基的氧化还原活性 Cys-596'/Sec-597' 对;Grx 结构域的活性位点包含一个氧化还原活性的 Cys-28/Cys-31 对。通过其 Cys-28/Cys-31 二硫键和/或 Cys-596'/Sec-597' 硫醇-硒醇,SmTGR 可以催化 NADPH 还原多种底物。据推测,SmTGR 通过 Cys-28/Cys-31 二硫键催化脱谷胱甘肽化反应。我们的厌氧滴定数据表明,NADPH 的还原当量确实可以到达 Grx 结构域中的 Cys-28/Cys-31 二硫键,以促进该半胱氨酸对的还原。为了阐明每个氧化还原活性残基对其各种反应性的具体化学作用,我们生成了 SmTGR 的变体。Cys-28 变体没有 Grx 脱谷胱甘肽化活性,而 Cys-31 变体保留了部分 Grx 脱谷胱甘肽化活性,表明 Cys-28 硫醇是引发脱谷胱甘肽化的亲核试剂。当野生型 SmTGR 在高浓度 GSSG 下孵育时,在稳态动力学中发现的滞后现象在 Grx 变体中不存在,这表明该半胱氨酸对在某种程度上负责滞后现象。Sec-597 变体仍然能够缓慢地还原多种底物,表明硒代半胱氨酸很重要,但不是酶对广泛底物耐受性的唯一决定因素。我们的数据表明 Cys-520 和 Cys-574 不太可能参与催化机制。